{"id":"W4226437517","doi":"10.1200/jco.2022.40.6_suppl.tps398","title":"Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"Population Health Research Institute; McMaster University Medical Centre; St. Joseph’s Healthcare Hamilton; Western University; Ontario Clinical Oncology Group; Health Sciences Centre; Ottawa Hospital; London Health Sciences Centre; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Renal cell carcinoma; Sunitinib; Kidney cancer; Oncology; Internal medicine; Nephrectomy; Immunotherapy; Urology; Cancer; Kidney","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001602103,0.001514834,0.001321215,0.0004203039,0.0004228677,0.00108173,0.001114824,0.00169683,0.006972285],"category_scores_gemma":[0.0009674107,0.000538961,0.001157179,0.0003288798,0.0009376004,0.0008296374,0.0004445588,0.003015097,0.001337348],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001295152,"about_ca_system_score_gemma":0.001774619,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001252686,"about_ca_topic_score_gemma":0.002273304,"domain_scores_codex":[0.9995571,0.0001817403,0.00001741225,0.0001073955,0.00004623295,0.00009009685],"domain_scores_gemma":[0.9993924,0.00007600945,0.000126263,0.0000574448,0.00003759931,0.0003102648],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8323558,0.05256794,0.002854107,0.0009373097,0.001503835,0.0002197814,0.0001892369,0.002211284,0.01894863,0.0006572805,0.006640283,0.08091456],"study_design_scores_gemma":[0.8134692,0.1780431,0.002737673,0.0000362355,0.0002835338,0.0001472733,0.00003166406,0.0008412209,0.001424508,0.0003352648,0.002632368,0.00001782801],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9752807,0.002920971,0.001383326,0.00150499,0.000616009,0.009862143,0.002439236,0.0002672779,0.005725295],"genre_scores_gemma":[0.9753548,0.001678303,0.002938401,0.002250183,0.0002937159,0.008554658,0.003351498,0.00005264444,0.005525779],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006972285,"threshold_uncertainty_score":0.02332461,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1422726296514713,"score_gpt":0.4789736089951704,"score_spread":0.3367009793436991,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}